-perone
Butyrophenone antipsychotics and tranquillizers.
- Drugs ending in -perone: 17
- Approved somewhere: 12
- With a US drug page: 7
- Stem
- -perone
- Class
- Butyrophenone antipsychotics and tranquillizers
- Most common targets
- HTR2A (8), DRD2 (8), D2-like dopamine receptor (3), SLC6A4 (1), HTR2C (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -perone or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Lumateperone | Approved | HTR2A, DRD2, SLC6A4 | Serotonin 2a (5-HT2a) receptor antagonist |
| Melperone | Phase 3 | — | — |
| Pipamperone | Phase 3 | — | — |
| Moperone | Phase 2 | — | — |
| Droperidol | Approved | HTR2A, D2-like dopamine receptor | Serotonin 2a (5-HT2a) receptor antagonist |
| Haloperidol decanoate | Approved | HTR2A, D2-like dopamine receptor | Serotonin 2a (5-HT2a) receptor antagonist |
| Benperidol | Approved | DRD2 | Dopamine D2 receptor antagonist |
| Bromperidol | Approved | DRD2 | Dopamine D2 receptor antagonist |
| Haloperidol | Approved | HTR2A, D2-like dopamine receptor | Serotonin 2a (5-HT2a) receptor antagonist |
| Trifluperidol | Approved | — | — |
| Iloperidone | Approved | DRD2, HTR2A | Dopamine D2 receptor antagonist |
| Paliperidone | Approved | DRD2, HTR2A | Dopamine D2 receptor antagonist |
| Paliperidone palmitate | Approved | DRD2, HTR2A | Dopamine D2 receptor antagonist |
| Risperidone | Approved | HTR2A, HTR2C, DRD2 | Serotonin 2a (5-HT2a) receptor antagonist |
| Domperidone | Approved | DRD2 | Dopamine D2 receptor antagonist |
| Roluperidone | Phase 3 | — | — |
| Etoperidone | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO